Abstract:A Western diet with enriched sugar and fat is implicated in cognitive impairment and the development of non‐alcoholic steatohepatitis (NASH). This study examines the impact of fermentable fiber inulin in shifting gut microbiota and metabolites to affect liver and brain health in Western diet‐fed mice. C57BL/6 mice were fed a healthy rodent control diet (CD) or a fructose, palmitate, and cholesterol (FPC)‐enriched diet after weaning until they were 3‐months old. Then, FPC diet‐fed mice were supplemented with or without 6% inulin for 5 months. All the mice were euthanized when they were 8 months of age. Long‐term consumption of the FPC diet induced NASH with elevated IL‐17A signaling. In addition, FPC diet reduced hippocampal long‐term potentiation (LTP) and induced microglia activation. Similarly, FPC diet induced Th17 pathway driven hepatic IL17A production along with increased IL17A inducers including Il1β, Il6, and Tgfβ. In contrast, inulin supplementation reduced these changes. Furthermore, FPC diet intake induced gut dysbiosis by increasing Proteobacteria whereas inulin supplementation prevented such changes. In the microbiota families Coriobacteriaceae and Erysipelotrichaceae, which are implicated in cholesterol metabolism, and the genus of Erysipelotrichaceae and Allobaculum also shifted in the same direction in response to FPC intake and inulin supplementation. Accordingly, cecum cholesterol and zymosterol, a precursor of cholesterol, were increased in FPC diet‐fed mice but reduced in inulin‐supplemented mice. In addition, FPC diet‐fed mice had reduced bile acid receptors TGR5 and FXR signaling, and inulin supplementation reversed such changes. The data suggest that inulin via gut fermentation shifts gut microbes, alters IL‐17A signaling, as well as activates bile acid receptor‐regulated pathways to coordinately ameliorate impaired neuroplasticity and neuroinflammation as well as NASH found in Western diet‐fed mice. Together, diet simultaneously affects brain and liver health. This study is supported by grants funded by National Institutes of Health U01CA179582 and R01CA222490 and Mouse Metabolic Phenotyping Center (MMPC) Microbiome Program (30835‐60), Subaward A19‐2654.

Inulin-enriched Megamonas funiformis ameliorates metabolic dysfunction-associated fatty liver disease by producing propionic acid

Lactobacillus Casei Yrl577 Ameliorates Markers Of Non-Alcoholic Fatty Liver And Alters Expression Of Genes Within The Intestinal Bile Acid Pathway

Amelioration of Obesity-Related Disorders in High-Fat Diet-Fed Mice following Fecal Microbiota Transplantation from Inulin-Dosed Mice

Inulin Exerts Beneficial Effects on Non-Alcoholic Fatty Liver Disease via Modulating gut Microbiome and Suppressing the Lipopolysaccharide-Toll-Like Receptor 4-Mψ-Nuclear Factor-κB-Nod-Like Receptor Protein 3 Pathway via gut-Liver Axis in Mice

Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis

Inulin intervention attenuates hepatic steatosis in rats via modulating gut microbiota and maintaining intestinal barrier function

Inulin Mitigates High Fructose-Induced Gut Dysbiosis and Metabolic Dysfunction in Mice

Akkermansia muciniphila alleviates high‐fat‐diet‐related metabolic‐associated fatty liver disease by modulating gut microbiota and bile acids

Concomitant Improvement of Synaptic Decline and NASH using Fermentable Fiber Inulin

Response of gut microbiota and ileal transcriptome to inulin intervention in HFD induced obese mice

Oral Administration of Compound Probiotics Ameliorates HFD-Induced Gut Microbe Dysbiosis and Chronic Metabolic Inflammation via the G Protein-Coupled Receptor 43 in Non-alcoholic Fatty Liver Disease Rats

Co-interventions with Clostridium Butyricum and Soluble Dietary Fiber Targeting the Gut Microbiota Improve MAFLD Via the Acly/Nrf2/NF-κB Signaling Pathway.

Inulin with different degrees of polymerization protects against diet-induced endotoxemia and inflammation in association with gut microbiota regulation in mice

Inulin alleviates inflammation of alcoholic liver disease via SCFAs-inducing suppression of M1 and facilitation of M2 macrophages in mice

Inulin alleviates atherosclerosis through improving lipid metabolism, inflammation, and gut microbiota in ApoE-knockout mice: the short-chain is more efficacious

Serum Metabolomics Uncovers the Mechanisms of Inulin in Preventing Non-Alcoholic Fatty Liver Disease

Inulin Supplementation Modulates the Hepatic Transcriptome, Metabolome, and Ferritin Content in Ovariectomized Rats

Akkermansia muciniphila Ameliorates Alcoholic Liver Disease in Experimental Mice by Regulating Serum Metabolism and Improving Gut Dysbiosis

Limosilactobacillus fermentum HNU312 alleviates lipid accumulation and inflammation induced by a high-fat diet: improves lipid metabolism pathways and increases short-chain fatty acids in the gut microbiome

Chain length‐dependent inulin alleviates diet‐induced obesity and metabolic disorders in mice

Remodeling Intestinal Microbiota Alleviates Severe Combined Hyperlipidemia-Induced Non-Alcoholic Steatohepatitis and Atherosclerosis in LDLR-/- Hamsters